STAT Plus: Controversy over the Ohio Medicaid program has provided a rare window into some of the fees paid to PBMs and the subsequent effect on drug prices. Now, an audit finds a new twist. https://buff.ly/2PdlJCV 

STAT Plus: Controversy over the Ohio Medicaid program has provided a rare window into some of the fees paid to PBMs and the subsequent effect on drug prices. Now, an audit finds a new twist. https://buff.ly/2PdlJCV 

More From BioPortfolio on "STAT Plus: Controversy over the Ohio Medicaid program has provided a rare window into some of the fees paid to PBMs and the subsequent effect on drug prices. Now, an audit finds a new twist. https://buff.ly/2PdlJCV "